By Sophora Health Editorial Team · Medically reviewed · Published July 2026 · Last reviewed July 2026
Perimenopause used to be understood as a transition that happened to women in their late 40s. Then they had a few hot flushes. Then periods stopped. That was the shape of it. What the research of the last two to three years has established is that this picture was wrong on almost every point. Wrong about who it happens to. Wrong about when it starts. Wrong about what the first signs are. And significantly wrong about how many women it is affecting at ages that the clinical system has not prepared for.
This is not a new disease. It is a familiar one being understood at a much higher resolution than before.
What has actually changed
A 2025 study by the University of Virginia and Flo Health analysed symptoms reported by more than 4,400 American women aged 30 and older. Among women aged 30 to 35, 55.4% reported symptoms meeting the criteria for moderate or severe on the Menopause Rating Scale. This rose to 64.3% for women aged 36 to 40. Despite this, most women do not seek treatment for menopause symptoms until they are 56 or older. The gap between when symptoms begin and when they are correctly identified and treated is, on average, more than 20 years. This is the new perimenopause: earlier than expected, more commonly unrecognised, and arriving in women who have been told they are too young for it.
Why the old picture was incomplete
The traditional model of perimenopause was built on the wrong starting point. For decades, doctors identified perimenopause primarily through changes in periods: shorter cycles, heavier bleeding, irregular timing. These changes are real, but they are not the earliest signs of the transition. They are signs that show up after the hormonal shift has already been underway for months or years. The earliest changes are harder to see.
A 2026 dataset identified by SFI Health found that symptoms often emerge before menstrual cycle changes, and that stable cycles do not rule out biological transition. Specific symptoms (hot flushes and vaginal dryness in particular) are turning out to be better indicators of perimenopause than cycle changes alone, and these symptoms were being experienced by women years before the diagnostic criteria would have identified them as perimenopausal.
The Menopause Society released findings in July 2026 confirming that many women report little prior knowledge about perimenopause, and clinicians typically receive inadequate training and education on perimenopause and menopause care. The combination of women who do not know what to look for and clinicians who do not ask means millions of women are living through the early years of a significant hormonal transition and explaining it to themselves as stress, getting older, or just a bad patch. None of these explanations help. They are also, frequently, wrong.
Someone important to you needs this too.
WhatsAppiMessageCopy LinkEmail
What is starting earlier and why
The first symptoms of perimenopause are not hot flushes. Hot flushes are a mid-to-late transition symptom driven by oestrogen instability. The earliest symptoms are driven by progesterone declining first, and they are significantly harder to connect to perimenopause because they do not look like what people expect perimenopause to look like.
Sleep disruption, particularly waking between 2 and 4am and then lying there for an extended and unwelcome period, is among the earliest. Anxiety that arrives without an obvious reason is among the earliest. Mood changes that feel different in quality from previous low periods. Periods that shift slightly in timing or character before becoming dramatically irregular. These are the signs that arrive in the late 30s and early 40s and are being attributed, in most clinical settings, to stress, work, or the general indignity of getting older. The advice received tends to involve more sleep, less caffeine, and stress management. None of this addresses what is actually happening.
Many women do not realise symptoms can begin in their 30s, leading to delayed recognition across regions. A 2025 survey of 1,000 adults published in the journal Women found that most people significantly underestimate how early perimenopause can begin, and that younger respondents were more likely to estimate an earlier onset than older respondents, suggesting that awareness is shifting in younger generations faster than in the clinical system.
Who is most affected by the recognition gap
The gap between symptom onset and recognition is not evenly distributed.
Women under 40 with perimenopausal symptoms face the strongest barrier. The two words most likely to come back from a clinical consultation are “too young.” These two words are frequently wrong. The Menopause Society found that younger women aged 35 to 39 were more likely to cite knowledge gaps, whereas healthcare barriers peaked in the 40 to 44-year-old age group. Women in their late 30s are being told they are too young. Women in their early 40s are hitting the healthcare system and finding it unprepared for them.
Black women experience the longest duration of vasomotor symptoms globally, and research consistently finds they are less likely to receive adequate treatment. Women in South Asian, Middle Eastern, and many African cultural contexts have no word for perimenopause in their native languages, which compounds the clinical invisibility. Women with demanding professional lives attribute symptoms to work stress with particular consistency. Women who are also caregiving for children and elderly parents simultaneously have the least capacity to investigate what is happening to their own bodies.
The women who are most affected by not having a framework for what is happening are not a small minority. They are the majority of women going through perimenopause.
The new perimenopause is not a different experience. It is the same experience being identified earlier, more accurately, and in women who were told they were too young for it to be happening.
What is changing in the clinical approach
The diagnostic framework is shifting from a cycle-first approach to a symptom-first approach. The 2024 NICE guideline update confirmed that women over 45 can be identified as perimenopausal on the basis of symptoms alone, without blood tests. This was a significant change from a framework that required hormonal confirmation. The recognition that blood tests are unreliable during perimenopause because hormones fluctuate so dramatically means that the clinical conversation is now supposed to be led by what the woman reports, not what the blood shows on a single day.
SFI Health’s 2026 review of international evidence called explicitly for updated diagnostic criteria that place greater emphasis on symptom presentation and reduce reliance on menstrual cycle markers as the primary identification tool. Multiple clinical bodies are now acknowledging that the current approach means women are being identified and treated years later than the evidence supports.
This shift matters enormously for younger women. If the diagnostic threshold requires irregular periods, women whose perimenopausal symptoms began before their cycle changed will not qualify for investigation. If the threshold is symptoms plus age-appropriate clinical suspicion, the conversation can begin years earlier and treatment can begin when it would have the most impact.
The digestive and neurological picture being mapped
Research at the Menopause Society 2025 annual meeting found that digestive symptoms are extremely common during perimenopause and almost entirely missed clinically. Bloating, constipation, stomach pain, and acid reflux were reported by 94% of participants. More than 80% said these symptoms started or got significantly worse during the transition. Fewer than a third had received any formal diagnosis or explanation for them. Fewer than a third received a formal diagnosis of any digestive condition.
This is part of a broader picture of the new perimenopause: symptoms that were previously not connected to the hormonal transition are now being mapped. The gut, the brain, the cardiovascular system, and the skeletal system are all affected by the hormonal changes of perimenopause in ways that clinical training has not historically prepared clinicians to identify. The connections are being mapped. The clinical response is behind.
What to do if you think you are in it earlier than expected
Do not accept “you are too young” as a complete answer. If you are under 40 with significant symptoms, ask specifically for assessment for premature ovarian insufficiency or early perimenopause rather than accepting a general dismissal. These are distinct conditions with different implications and different management approaches.
Document what you are experiencing specifically. Sleep changes, mood changes, cycle changes, energy changes, cognitive changes, and physical changes should all be recorded with dates and frequency. Three months of documented symptoms is a significantly stronger basis for a clinical conversation than a general sense that things have shifted.
Ask for a menopause-trained clinician. The awareness gap exists at the clinical level as much as at the individual level. A clinician with specific menopause training is more likely to recognise early or atypical presentation than a general practitioner without it.
Sophora’s Doctor Prep document can help you build a clear, organised account of your symptoms before a clinical appointment, so the conversation starts from a documented picture rather than from a ten-minute window where you have to recall months of experience from memory.
Questions you are probably asking
Is perimenopause actually starting earlier, or are we just recognising it earlier?
Both, and the distinction matters less than it might seem. The biological transition itself is starting in the late 30s for a significant proportion of women, as the UVA and Flo research demonstrates. But it is also being identified earlier in women whose perimenopause started at the historically expected age, because the diagnostic tools and clinical awareness have improved. The practical effect is the same: more women are being correctly identified as perimenopausal, at younger ages, than at any previous point in medical history.
If I am 37 and having these symptoms, what should I do?
Ask for specific assessment rather than general reassurance. Symptoms appearing before 40 can indicate early perimenopause, premature ovarian insufficiency, or other hormonal conditions, all of which have specific and different management approaches. “You are too young for menopause” is not an investigation. It is a dismissal. You are entitled to an investigation.
What does the new perimenopause mean for treatment?
It means earlier treatment is both possible and beneficial. The evidence for HRT’s protective effects on bone health, cardiovascular health, and cognitive function is strongest when treatment begins closer to the onset of the transition rather than years into it. Women identified earlier have more options, better outcomes, and the bone and heart protection that early HRT provides. Women identified at 56 after two decades of unmanaged symptoms do not get those years back.
You now know: More than half of women aged 30 to 35 report moderate to severe perimenopausal symptoms. The gap between symptom onset and treatment averages more than 20 years. The diagnostic framework is shifting toward symptoms, away from cycle changes as the primary marker. Younger women are the most affected by the recognition gap.
One thing to do: If you have been told you are too young for perimenopause but the symptoms match, document them specifically for three months and request assessment from a menopause-trained clinician rather than a general reassurance.
Hold onto this: The new perimenopause is not a different experience. It is the same experience being identified earlier, more accurately, and in women who were told they were too young for it to be happening.
Someone important to you needs this too.
WhatsAppiMessageCopy LinkEmail
The next step
Sophora’s Symptom Decoder is built for the woman who has symptoms but no confirmed diagnosis. It reads what you describe and names what it sees, without requiring you to already know what it is. Private. Account-bound. Never sold, never used for advertising, never used to train public AI models.
mysophora.com · One payment. Twelve months. No subscription.
The new perimenopause is not a different experience. It is the same experience being identified earlier, more accurately, and in women who were told they were too young for it to be happening.
Last reviewed: July 2026 · Review due: September 2026 · Not therapy. Not medical advice. For your own use and understanding only. · mysophora.com